Bone and Muscle Health Through Menopause: What to Discuss With Your Clinician

Bone is living tissue that continuously breaks down and rebuilds itself through a process called remodelling. Estrogen plays a regulatory role in this cycle, helping to slow the rate at which old bone is removed. When estrogen levels fall during perimenopause and after menopause, bone removal can temporarily outpace new bone formation, leading to a gradual reduction in bone density over time. This does not happen uniformly or at the same rate in everyone, and many factors (including genetics, previous physical activity, and nutritional history) influence how pronounced the change is.

It is important to distinguish between reduced bone density and osteoporosis. Reduced density is a measurable change on a spectrum; osteoporosis is a clinical diagnosis made when density falls below a defined threshold and fracture risk increases significantly. NHS guidance on osteoporosis explains that the condition often develops without symptoms, which is why the bone changes associated with menopause deserve attention even when nothing feels wrong. A concern about bone health is not the same as a diagnosis, and a clinician is best placed to assess individual risk.

Alongside bone changes, many people notice shifts in muscle mass and strength during and after menopause. Estrogen has a role in maintaining muscle protein synthesis and may influence how efficiently muscles recover after exertion. As levels decline, some people find that maintaining the same level of physical capacity requires more deliberate effort than before, or that recovery after activity takes longer.

This is sometimes described as sarcopenia when it progresses to a clinically significant loss of muscle mass and function, though that term refers to a specific condition rather than the normal variation most people experience. The practical concern is that reduced muscle strength can affect balance, posture, and the ability to absorb impact, all of which interact with bone health. Weaker muscles place more direct stress on bones during everyday movement. Raising this with a clinician is sensible if you notice meaningful changes in your strength or stamina, particularly if they feel disproportionate to your activity level or age.

Joint aches and stiffness are among the less-discussed symptoms of menopause, yet they are reported by many people going through this transition. NHS information on menopause symptoms includes musculoskeletal discomfort in its list of recognized symptoms, which can be reassuring for those who have not connected these experiences to hormonal change.

The mechanisms are not fully established, but estrogen receptors are present in joint tissue, and reduced levels may affect the lubrication and inflammatory responses within joints. It is worth being cautious about assuming all joint discomfort during this period is menopause-related, however. Conditions such as inflammatory arthritis, hypothyroidism, or vitamin D deficiency can produce similar symptoms and have different management pathways. If joint pain is severe, asymmetrical, accompanied by swelling, or significantly limits daily activity, it warrants clinical assessment rather than being attributed to menopause without investigation.

Bone density is measured using a DEXA (dual-energy X-ray absorptiometry) scan, which is a low-radiation imaging test that produces a score comparing your bone density to reference values. A DXA scan can contribute to diagnosis and fracture-risk assessment. Its findings should be interpreted alongside clinical history and relevant risk factors, with additional tools used where appropriate.

Not everyone going through menopause will be referred for a DEXA scan, and whether one is appropriate depends on individual circumstances including age, family history, previous fractures, and other health factors. NICE guidance on menopause identification and management addresses the clinical considerations around bone health in the context of menopause management. If you are uncertain whether a bone density assessment is relevant for you, asking your clinician to explain the reasoning, in either direction, is entirely reasonable. A scan result showing lower density than average is not automatically alarming; its significance depends on the full clinical picture.

Calcium and vitamin D are both necessary for bone maintenance, and their adequacy becomes particularly relevant during and after menopause. Calcium is the primary mineral in bone tissue, while vitamin D is essential for calcium absorption from food. A diet consistently low in either can contribute to faster bone loss, though supplementation is not universally recommended and depends on individual dietary intake and blood levels.

Vitamin D deficiency is relatively common and can be assessed with a blood test. Symptoms of deficiency (including fatigue, muscle weakness, and bone discomfort) can overlap with menopause symptoms, which makes clinical assessment useful rather than assuming one cause. Food sources of calcium include dairy products, fortified plant milks, leafy green vegetables, and fish with edible bones. Discussing your usual diet with a clinician or registered dietitian can help identify whether nutritional gaps are likely and whether any supplementation is appropriate for your situation. Self-prescribing high-dose supplements without guidance is not advisable, as excess calcium or vitamin D carries its own risks.

Different types of physical activity affect bone and muscle health in distinct ways, and understanding the distinction helps when discussing options with a clinician or physiotherapist. Weight-bearing activity, where you support your own body weight against gravity, provides mechanical stimulus to bone, encouraging it to maintain density. Resistance-based activity, which involves working muscles against load, supports muscle mass and strength.

Swimming and cycling, while excellent for cardiovascular health, are not weight-bearing in the relevant sense and do not provide the same bone stimulus as walking, dancing, or strength training. This does not mean they have no value (overall fitness, joint mobility, and mental well-being all matter) but it does mean that relying solely on non-weight-bearing activity may not address bone health specifically. If you have existing joint problems, osteoporosis, or other conditions that affect what movement is safe, a physiotherapist can help identify appropriate options. General public health guidance on activity levels provides a starting point, but individual circumstances vary considerably.

Hormone replacement therapy (HRT) replaces some of the estrogen lost during menopause and has a well-established effect on slowing the bone loss associated with estrogen decline. NICE guidance discusses HRT in the context of menopause management, including its effects on bone. Whether HRT is appropriate for any individual involves weighing potential benefits against risks and personal health history. It is a clinical conversation, not a universal recommendation.

For those who cannot take or choose not to take HRT, other approaches to bone health may be discussed, including lifestyle measures and, in some cases, medication specifically targeting bone density. These decisions are made on an individual basis with a clinician. HRT decisions are often made for multiple reasons simultaneously, bone health may be one consideration alongside symptom management, and the conversation with a clinician can address all of these together rather than treating them as separate issues.

Arranging a focused conversation about bone and muscle health during menopause is more productive when you arrive with some preparation. Consider noting any symptoms you have noticed (joint stiffness, changes in strength, balance concerns, or increased fatigue) along with when they started and whether they affect daily activities. Family history of osteoporosis or fractures is relevant, as is any previous fracture you have had as an adult, even if it seemed minor at the time.

Questions worth raising might include: whether a bone density assessment is appropriate given your history; what your current risk factors are; whether your diet and activity level are broadly adequate for bone health; and what signs would warrant a follow-up appointment. You do not need to arrive with answers. The purpose is to give your clinician enough context to advise you well. If you feel a concern was not addressed, asking for clarification or a follow-up is reasonable. Bone and muscle health through menopause is a legitimate clinical topic, not a minor or cosmetic one.

Changes in sleep, concentration, nutrition, movement, and recovery may be relevant to a broader SENSES health assessment. Bring your questions and any existing clinical information so that the review can consider your circumstances and current care.

These guides provide education about women’s health and menopause. They do not establish that specialist menopause consultations, hormone testing, or prescribing are included in a SENSES program. Confirm the appropriate professionals and any external referrals through the individual suitability discussion.

Ask how the result changes advice for the activities you already do and those you would like to resume. Bone density, fracture history, falls risk, pain and current capacity can all affect the conversation. A scan score alone does not specify a safe exercise program.

The NIAMS bone-density guide explains the importance of interpreting results with other risk factors. WHO physical-activity guidance provides a broad framework, but individual adaptation may be needed.

Clarify which professional can help translate the findings into appropriate movement and whether further assessment is needed. The bone-density testing guide and physical-capacity guide distinguish measurement from a plan. Agree on follow-up rather than assuming that taking a supplement or joining a class addresses every concern.

Read women’s health guides, midlife support and muscle health with age.

• NICE NG23: Menopause identification and management
• NIAMS: Bone mineral density tests
• NHS: Osteoporosis
• WHO guidelines on physical activity and sedentary behaviour
• NHS information on menopause symptoms
• NICE guidance on menopause identification and management

General educational information. Individual assessment and treatment decisions belong with an appropriately qualified clinician.